Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.5088
Delayed Data
As of Apr 28
 -0.1759 / -25.69%
Today’s Change
0.36
Today|||52-Week Range
3.46
+36.70%
Year-to-Date

Today’s Trading

Previous close0.68
Today’s open0.55
Day’s range0.50 - 0.56
Volume25,738,684
Average volume (3 months)2,917,525
Market cap$59.7M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+35.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+100.00%
P/E ratioNM
Price/Sales150.86
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
BPTHBio Path Holdings In...-0.04-5.86%
PSDVpSivida Corp0.000.00%
COOLPolarityte Inc-0.47-3.96%
ADMAADMA Biologics Inc+0.00+0.11%
Data as of 3:59pm ET, 04/28/2017

Financials

Last reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$200.0K
Annual profit (last year)-$50.8M
Net profit margin-25,385.61%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Steven A. Kriegsman
Chief Operating &
Medical Officer
Daniel J. Levitt
Corporate headquarters
Los Angeles, California

Forecasts